Invesco Biotechnology & Genome ETF
PBE
#1831
ETF rank
NZ$0.44 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$142.03
Share price
-0.06%
Change (1 day)
18.50%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of December 4, 2025

Number of holdings: 31

Full holdings list

Weight %NameTickerShares Held
5.30%Alnylam Pharmaceuticals IncALNY29494
5.09%Biogen IncBIIB72430
5.07%Amgen IncAMGN38293
5.03%Illumina IncILMN101676
5.02%United Therapeutics CorpUTHR26838
4.84%Gilead Sciences IncGILD102236
4.70%Regeneron Pharmaceuticals IncREGN16819
4.68%Incyte CorpINCY120549
3.09%BioCryst Pharmaceuticals IncBCRX1022796
3.00%MannKind CorpMNKD1361734
3.00%ACADIA Pharmaceuticals IncACAD292289
2.95%Neurocrine Biosciences IncNBIX49456
2.83%Exelixis IncEXEL165342
2.81%Ionis Pharmaceuticals IncIONS88967
2.80%Collegium Pharmaceutical IncCOLL153076
2.74%Veracyte IncVCYT149587
2.71%Amicus Therapeutics IncFOLD706339
2.70%Bio-Techne CorpTECH110028
2.69%Madrigal Pharmaceuticals IncMDGL11882
2.69%QIAGEN NVQGEN147939.1353
2.69%Protagonist Therapeutics IncPTGX79664
2.68%Royalty Pharma PLCRPRX175741
2.67%Repligen CorpRGEN41766
2.65%Catalyst Pharmaceuticals IncCPRX296898
2.64%TG Therapeutics IncTGTX218099
2.63%PTC Therapeutics IncPTCT87507
2.62%BioMarin Pharmaceutical IncBMRN125869
2.58%Dynavax Technologies CorpDVAX609709
2.55%Vericel CorpVCEL179673
2.30%Halozyme Therapeutics IncHALO94401
0.23%CASH & EQUIVALENTSUSD585253.42